0001171843-23-001596.txt : 20230310 0001171843-23-001596.hdr.sgml : 20230310 20230310165139 ACCESSION NUMBER: 0001171843-23-001596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Colleran David CENTRAL INDEX KEY: 0001646558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 23724425 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK DRIVE STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2023-03-09 0 0000898437 Anika Therapeutics, Inc. ANIK 0001646558 Colleran David 32 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 EVP, General Counsel, Corp Sec Common Stock 2023-03-09 4 M 0 3683 0 A 15956 D Common Stock 2023-03-09 4 F 0 1081 26.91 D 14875 D Restricted Stock Unit 0.00 2023-03-09 4 A 0 16395 0 A Common Stock 16395 16395 D Stock Option (Right to Buy) 29.60 2023-03-09 4 A 0 35790 0 A 2033-03-09 Common Stock 35790 35790 D Restricted Stock Unit 0.00 2023-03-09 4 M 0 3683 0 D Common Stock 3683 3682 D Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023. Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. Represents a 10% premium above the closing price of Anika's common stock on the date of grant. The premium priced stock options vest in three equal annual installments beginning on March 9, 2024. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. /s/ David Colleran 2023-03-10